基于英国药物警戒和英格兰一般实践处方数据的药品比较安全性分析。
A Comparative Safety Analysis of Medicines Based on the UK Pharmacovigilance and General Practice Prescribing Data in England.
机构信息
College of Medicine and Health, University of Exeter Medical School, Exeter, U.K.
出版信息
In Vivo. 2022 Mar-Apr;36(2):780-800. doi: 10.21873/invivo.12765.
Abstract
BACKGROUND/AIM: Adverse drug reactions (ADRs) represent a major concern leading to significant increases in both morbidity and mortality globally. Providing healthcare professionals (HCPs) and patients with real-world data on drug safety is imperative to facilitate informed decision-making. The study aimed to determine the feasibility of creating comparative safety charts for medicines by mapping ADR reporting onto prescribing data.
MATERIALS AND METHODS
Data on serious and fatal ADR reports from the Yellow Card database was mapped onto general practice prescription data in England. The rate of serious and fatal ADR reports per million items prescribed was calculated for commonly-prescribed medicines.
RESULTS
Quantitative comparative analyses for 137 medicines belonging to 26 therapeutic classes were conducted. Significant differences were observed within most therapeutic classes for the rate of serious and fatal ADR reports per prescribing unit.
CONCLUSION
Despite the limitations of ADR reporting and prescribing databases, the study provides a proof-of-concept for the feasibility of mapping ADR reporting onto prescribing data to create comparative safety charts that could support evidence-based decision-making around formulary choices.
摘要
背景/目的：药物不良反应（ADR）是一个主要关注点，导致全球发病率和死亡率显著上升。为医疗保健专业人员（HCP）和患者提供有关药物安全性的真实世界数据对于促进明智决策至关重要。本研究旨在通过将药物不良反应报告映射到处方数据来确定为药物创建比较安全性图表的可行性。
材料和方法
将严重和致命药物不良反应报告的数据从黄卡数据库映射到英国的一般实践处方数据上。计算了常用药物的每百万处方单位严重和致命药物不良反应报告的发生率。
结果
对属于 26 个治疗类别的 137 种药物进行了定量比较分析。在大多数治疗类别中，每处方单位严重和致命药物不良反应报告的发生率存在显著差异。
结论
尽管药物不良反应报告和处方数据库存在局限性，但该研究为将药物不良反应报告映射到处方数据以创建支持药物选择决策的基于证据的比较安全性图表的可行性提供了概念验证。
相似文献
1
A Comparative Safety Analysis of Medicines Based on the UK Pharmacovigilance and General Practice Prescribing Data in England.基于英国药物警戒和英格兰一般实践处方数据的药品比较安全性分析。
In Vivo. 2022 Mar-Apr;36(2):780-800. doi: 10.21873/invivo.12765.
2
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.评估患者向英国“黄卡计划”报告药物不良反应的情况：文献回顾、描述性和定性分析以及问卷调查。
Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200.
3
Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review.患者与医疗保健专业人员自发药物不良反应报告：系统评价。
Drug Saf. 2012 Oct 1;35(10):807-18. doi: 10.1007/BF03261977.
4
Under-reporting of gastrointestinal bleeding associated with anticoagulant use using the UK Yellow Card Scheme.英国黄卡计划中与抗凝药物使用相关的胃肠道出血漏报情况。
Int J Clin Pharm. 2023 Aug;45(4):1014-1018. doi: 10.1007/s11096-023-01601-0. Epub 2023 Jun 3.
5
Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review.土耳其医疗保健专业人员对药物警戒和药品不良反应报告的知识、态度、实践及障碍：一项系统综述
Curr Med Res Opin. 2022 Jan;38(1):145-154. doi: 10.1080/03007995.2021.1997287. Epub 2021 Nov 3.
6
The UK BIO-TRAC Study: A Cross-Sectional Study of Product and Batch Traceability for Biologics in Clinical Practice and Electronic Adverse Drug Reaction Reporting in the UK.英国 BIO-TRAC 研究：英国临床实践中生物制剂的产品和批次可追溯性以及电子药物不良反应报告的横断面研究。
Drug Saf. 2020 Mar;43(3):255-263. doi: 10.1007/s40264-019-00891-6.
7
First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.法国首次报告大流行流感疫苗（H1N1）接种后患者不良反应：患者和医务人员报告的比较。
Drug Saf. 2012 Oct 1;35(10):845-54. doi: 10.1007/BF03261980.
8
Nonmedical prescriber experiences of training and competence to report adverse drug reactions in the UK.英国非医学开处方者报告药品不良反应的培训及能力经验
J Clin Pharm Ther. 2019 Feb;44(1):78-83. doi: 10.1111/jcpt.12756. Epub 2018 Sep 11.
9
An observational study to compare the contents and quality of information furnished in CDSCO ADR reporting form, yellow card, medwatch and blue form by the healthcare professionals.一项观察性研究，旨在比较医疗保健专业人员在CDSCO药品不良反应报告表、黄卡、MedWatch和蓝色表格中提供的信息内容和质量。
Int J Risk Saf Med. 2014;26(1):1-8. doi: 10.3233/JRS-140608.
10
Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.全球范围内十年来药物不良反应模式分析：来自 VigiBase™ 的自发报告
Drug Saf. 2012 Dec 1;35(12):1171-82. doi: 10.1007/BF03262002.
引用本文的文献
1
Is it appropriate to conduct a disproportionality analysis using a spontaneous reporting database to investigate whether drug-related adverse events are dose-dependent?使用自发报告数据库进行不成比例分析以调查药物相关不良事件是否与剂量相关是否合适？
Front Pharmacol. 2025 Aug 29;16:1563524. doi: 10.3389/fphar.2025.1563524. eCollection 2025.
2
Chronic Kidney Disease Following Cardiac Arrest Manifesting as Dyspnoea and Peripheral Oedema in Cardiovascular Multimorbidity: Case Analysis and Brief Literature Review.心脏骤停后并发慢性肾脏病，在心血管多重疾病中表现为呼吸困难和外周水肿：病例分析与文献简要综述
In Vivo. 2025 Mar-Apr;39(2):1182-1189. doi: 10.21873/invivo.13922.
3
A Time-varying Analysis of General Practice Prescribing in the COVID-19 Era: Lessons from Prescription Dynamics in a Pandemic.新冠疫情时代全科医疗处方的时变分析：大流行中处方动态的经验教训
In Vivo. 2025 Jan-Feb;39(1):498-508. doi: 10.21873/invivo.13854.
4
Transient Ischaemic Attack in a Patient With Conn Syndrome: A Case Report and Literature Review on the Importance of Identifying Secondary Hypertension.原发性醛固酮增多症患者的短暂性脑缺血发作：病例报告及关于识别继发性高血压重要性的文献综述
In Vivo. 2025 Jan-Feb;39(1):566-571. doi: 10.21873/invivo.13861.
5
Heart Failure Masked as Pulmonary Embolism in Non-adherent Patient With Atrial Fibrillation: Case Report and Analytical Review of the Literature.房颤非依从性患者中伪装为肺栓塞的心力衰竭：病例报告及文献分析综述
In Vivo. 2025 Jan-Feb;39(1):548-558. doi: 10.21873/invivo.13859.
6
Chest Pain at Rest With Unremarkable ECG and Cardiac Enzymes: Case Study Emphasising the Importance of Clinical Suspicion in the Diagnosis of Coronary Artery Disease.静息时胸痛伴心电图及心肌酶无异常：病例研究强调临床怀疑在冠状动脉疾病诊断中的重要性。
In Vivo. 2025 Jan-Feb;39(1):524-531. doi: 10.21873/invivo.13856.
7
Cross-sectional study of pharmacovigilance knowledge, attitudes, and practices based on structural equation modeling and network analysis: a case study of healthcare personnel and the public in Yunnan Province.基于结构方程模型和网络分析的药物警戒知识、态度和实践的横断面研究：云南省医护人员和公众的案例研究。
Front Public Health. 2024 Mar 19;12:1358117. doi: 10.3389/fpubh.2024.1358117. eCollection 2024.
本文引用的文献
1
Preventability, predictability, severity and causality assessment of adverse drug reactions reported from a teaching hospital in chhattisgarh: A retrospective analysis.恰蒂斯加尔邦一家教学医院报告的药物不良反应的可预防性、可预测性、严重性及因果关系评估：一项回顾性分析
J Family Med Prim Care. 2021 Jul;10(7):2541-2545. doi: 10.4103/jfmpc.jfmpc_2374_20. Epub 2021 Jul 30.
2
Prevalence of adverse drug reactions in the primary care setting: A systematic review and meta-analysis.基层医疗环境中药物不良反应的发生率：系统评价和荟萃分析。
PLoS One. 2021 May 26;16(5):e0252161. doi: 10.1371/journal.pone.0252161. eCollection 2021.
3
How to perform a meta-analysis with R: a practical tutorial.如何使用 R 进行荟萃分析：实用教程。
Evid Based Ment Health. 2019 Nov;22(4):153-160. doi: 10.1136/ebmental-2019-300117. Epub 2019 Sep 28.
4
Incidence, causes, and consequences of preventable adverse drug reactions occurring in inpatients: A systematic review of systematic reviews.住院患者中可预防药物不良反应的发生率、原因和后果：系统评价的系统评价。
PLoS One. 2018 Oct 11;13(10):e0205426. doi: 10.1371/journal.pone.0205426. eCollection 2018.
5
Pharmacovigilance: An Overview.药物警戒：概述。
Clin Ther. 2018 Dec;40(12):1991-2004. doi: 10.1016/j.clinthera.2018.07.012. Epub 2018 Aug 17.
6
Frequent Adverse Drug Reactions, and Medication Groups under Suspicion.频繁不良反应及疑似药物类别。
Dtsch Arztebl Int. 2018 Jun 8;115(23):393-400. doi: 10.3238/arztebl.2018.0393.
7
What Future Healthcare Professionals Need to Know About Pharmacovigilance: Introduction of the WHO PV Core Curriculum for University Teaching with Focus on Clinical Aspects.未来医疗保健专业人员需要了解的药物警戒知识：引入世卫组织药物警戒核心课程用于大学教学，重点关注临床方面。
Drug Saf. 2018 Nov;41(11):1003-1011. doi: 10.1007/s40264-018-0681-z.
8
Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature.迫切需要使医疗保健课程中的药物警戒教育现代化：文献综述
Eur J Clin Pharmacol. 2018 Oct;74(10):1235-1248. doi: 10.1007/s00228-018-2500-y. Epub 2018 Jun 20.
9
Deaths from Medicines: A Systematic Analysis of Coroners' Reports to Prevent Future Deaths.药物致死：通过验尸官报告系统分析以预防未来死亡。
Drug Saf. 2018 Jan;41(1):103-110. doi: 10.1007/s40264-017-0588-0.
10
Identifying High-alert Medications in a University Hospital by Applying Data From the Medication Error Reporting System.应用药物错误报告系统数据识别大学医院高警示药物。
J Patient Saf. 2021 Sep 1;17(6):417-424. doi: 10.1097/PTS.0000000000000388.
Zotero 插件